LASR — nLIGHT, Inc.
Thesis
Verdict: WATCH / "right company, possibly wrong price." Medium conviction — high on the technology and market position, low on the entry price. nLIGHT is a vertically integrated high-power laser company that pivoted from a commoditizing industrial laser business into a defense-dominant directed energy play. It demonstrated a 300kW-class fiber laser weapon (the most powerful fiber-based directed energy system publicly shown), holds a $171M HELSI contract to scale to megawatt-class, and is one of only 2–3 companies with demonstrated capability at this power level. The directed energy market is inflecting: cheap drones devastate modern battlefields and missile interceptors cost $1M+ per shot, making laser weapons (dollars per shot) an economic imperative. A&D is now 67% of FY2025 revenue, up from 36% in FY2022.
The price has run ahead of the fundamentals. The stock went from ~$6 to ~$73 in a year, trades at ~14x sales with no sustained GAAP profitability (25 years of recurring net losses), and even bullish analysts have an average target ($50.56) ~23% below the price. At $65.76 the market cap is $3.67B / EV ~$3.57B against $261.3M LTM revenue — implying nLIGHT roughly triples revenue to ~$700–800M+ and hits 15–20% operating margins within 4–5 years. That is possible if directed energy production contracts materialize, but it is a lot to pay today.
Two structural drags pull the management grade to B+ despite a genuinely impressive founder: (1) stock-based comp at 11–14% of revenue every year — the primary reason the company has never been sustainably GAAP profitable, driving share count up 69% since IPO (33M → 55.8M); and (2) all-selling, zero-buying insider activity ($20M+ sold over six months, not a single open-market purchase). The next gates are HELSI Phase 2 megawatt-class milestones (2027–2028) and the production-contract selection vs. Lockheed Martin's slab architecture (likely 2028–2030, worth potentially billions). This is a good company you want to own at a price you should not chase — scale in, don't lump.
Snapshot
One-liner: nLIGHT makes the lasers the U.S. military wants on Stryker vehicles to shoot down drones — vertically integrated from semiconductor pump diode through complete directed energy weapon system, the purest listed fiber-laser directed energy play, but pricing in enormous success at ~14x sales with no sustained GAAP profit.
- Ticker / exchange: LASR on Nasdaq
- Legal name: nLIGHT, Inc.; HQ Camas, Washington; founded June 2000 (Scott Keeney, Jason Farmer, Mark DeVito); reincorporated Delaware / renamed nLIGHT, Inc. Jan 2016; IPO April 2018 at $16/share (raised $86.4M, 5.4M shares); nlight.net
- Sector / industry: Industrials > Electrical Equipment (GICS); realistically a defense laser technology company. Sits at the fiber laser ⨯ directed energy intersection — see defense-technology.
- Spot price: $65.76 (as of 2026-03-21/22 deep-dive snapshot — verify live before any PT math); 52-wk range $6.20–$72.90 (ran ~10x off the low in a year)
- Market cap: $3.67B | EV ~$3.57B (net cash ~$97.4M: $133.6M cash − $36.2M debt)
- Valuation: P/E N/M (negative GAAP earnings) | EV/Revenue (TTM) ~13.7x | EV/EBITDA ~152x | P/FCF ~298x | Forward P/E (FY26E) ~203x | FCF yield ~0.3% | Dividend yield 0% | beta 2.34
- Shares: 55.79M outstanding; insiders ~4% (CEO Keeney 2.23M ≈ ~$147M); institutional ~81–84% (286 holders; Vanguard ~9.6%, BlackRock ~8.9%)
- Coverage: thin — 8 analysts, all bullish (5 Strong Buy, 3 Buy, 0 Hold/Sell); consensus Strong Buy; avg target $50.56 (−23% vs spot), median $55.00, high $95.00 (Baird, initiated 4 Mar 2026), low $24.00. Even the bulls think the stock is ahead of itself. Short interest modest (2.38M / 4.52% of float / 1.41 days to cover).
- Conviction: Medium — WATCH at spot; scale in on pullbacks to $45–50; full size only on HELSI Phase 2 progress or production-contract awards
Business
What it does. nLIGHT designs and manufactures high-power semiconductor laser diodes (the fundamental light sources), fiber lasers (which use those diodes as pump sources), and complete directed energy weapon systems for the U.S. military. It also makes specialty optical fiber (LIEKKI brand, made in Finland), medical/industrial fiber lasers, and laser process-monitoring systems. "nLIGHT makes the lasers the U.S. military wants to put on Stryker vehicles to shoot down drones" is the story in one sentence — but it is more, built on a vertically integrated stack spanning from the semiconductor wafer to the complete beam director system.
Business model. Product sales of laser diodes, fiber lasers, and components to industrial and medical OEMs, plus cost-plus and fixed-price government R&D contracts for directed energy weapon development (HELSI, DE M-SHORAD). Revenue is shifting heavily toward defense: A&D 67% of FY2025 revenue, up from 36% in FY2022. ~800 employees.
Segments.
| Segment | Description | ~% of Revenue (FY25) |
|---|---|---|
| Laser Products | Semiconductor laser diodes, fiber lasers, specialty optical fiber, components | ~40–45% |
| Advanced Development | Directed energy weapon systems, beam combining, adaptive optics, government R&D | ~55–60% |
Geographic mix is predominantly U.S. (driven by defense), with international exposure via LIEKKI fiber (Finland) and some industrial/medical OEM sales in Europe/Asia. Latest investor presentation: Q4 FY2025 (26 Feb 2026), at investors.nlight.net.
Product lines.
- Semiconductor laser diodes (element + pearl): GaAs chips converting electricity to laser light. element — high-power, high-brightness up to 700W/module, 793–976nm, the workhorse for pumping fiber lasers; ASP $1,000–$10,000+. pearl — flexible multi-purpose, 640–1550nm, medical/scientific/aerospace; ASP hundreds of dollars. Compete vs Coherent/II-VI, Lumentum, IPG (internal), Chinese (BWT, Focuslight). Edge: best-in-class brightness, 20+ yrs reliability data, U.S.-made for defense qualification. Stable-to-modest growth.
- Corona AFX programmable fiber lasers: 1–2kW lasers that electronically switch between 7 beam profiles in real time — beam shaping built into the fiber (no mechanical parts, no external optics, no downtime), like a zoom lens inside the fiber. For metal additive manufacturing: 3x faster builds, 2–6x cost savings, 82% build-time reduction (Aconity3D). ASP ~$50,000–$150,000+. Protected by 30+ patents, no direct competitor equivalent. Early innings, high potential (metal AM ~$3–4B, 20–25% CAGR).
- Medical TFL fiber lasers: 2-micron (thulium) fiber laser for urology/surgery, up to 625W peak, air-cooled. 2μm is strongly water-absorbed, ideal for soft-tissue ablation; displacing holmium:YAG in lithotripsy. ASP $50,000–$200,000. Niche but growing, recurring revenue from consumable fibers/service.
- LIEKKI specialty optical fibers: Active (rare-earth doped) and passive fibers, made in Lohja, Finland (acquired ~2008–09). Direct nanoparticle deposition gives highest absorption coefficients in the industry (30% shorter fiber needed). Critical vertical-integration piece — reduces dependence on Nufern/Coherent, Fujikura. ASP $10–$100+/meter.
- Directed energy weapon systems: Complete high-energy laser systems — fiber laser arrays, spectral/coherent beam combining, adaptive optics, beam directors. ASP $10M–$100M+ per development/prototype system; production units likely $5–20M. This is where the stock story lives.
Defense programs.
| Program | Contract Value | Power Level | Purpose | Status |
|---|---|---|---|---|
| HELSI Phase 2 | $171M | Megawatt-class (1MW+) | Strategic directed energy weapon | Active development; revenue over ~2 yrs + follow-on production $500M–1B+ potential |
| DE M-SHORAD | $34.5M | 50kW | Counter-drone on Stryker vehicles | Prototype delivery; production depends on Army evaluation |
| HELSI Phase 1 | $86M (part of above) | 300kW demonstrated | Proof of concept | Completed, exceeded objectives |
Operations footprint. HQ & laser-diode fab (Camas, WA); additional manufacturing/engineering (Vancouver, WA); Nutronics directed-energy beam combining & adaptive optics (Longmont, CO — being expanded to 50K+ sq ft with Feb 2026 offering proceeds, the most strategically important capex project, supporting HELSI megawatt-class scaling); LIEKKI fiber (Lohja, Finland); OPI Photonics component/packaging (Torino, Italy); limited Shanghai operations.
Partnerships (no formal JVs). EOS (global leader in industrial metal 3D printing, ~$1B revenue) — joint strategic cooperation announced June 2024, embedding Corona AFX into next-gen metal printers; the marquee commercial design win. DMG Mori / AMCM — also adopted Corona AFX. U.S. DoD — direct contractor on HELSI and DE M-SHORAD; works both directly with agencies and alongside primes (LMT, RTX, NOC, BA) as a component supplier.
First principles — why fiber lasers and why directed energy. Stimulated emission (Einstein, 1917) confined in a resonator is how every laser works. For fiber lasers: GaAs pump diodes (~976nm) inject light into ytterbium-doped fiber; pump photons create population inversion; fiber Bragg gratings act as mirrors; output is a coherent ~1060–1080nm beam. The key enabler is double-clad fiber — a doped core (~10–30μm) inside a larger inner cladding (~125–400μm) decouples pump quality from output beam quality (cheap, sloppy pump diodes → beautiful output beam, like a water filter). Fiber lasers beat CO2 and Nd:YAG on wall-plug efficiency (30–50% vs 10–15% / 2–5%), beam quality, maintenance, and SWaP — they won the industrial market in the 2010s. A single fiber tops out at ~5–10kW before nonlinear effects degrade the beam; to reach 50–300kW+ you combine many lasers: Spectral Beam Combining (SBC — passive, robust; Lockheed's HELSI approach) or Coherent Beam Combining (CBC — phase-locked, theoretically higher brightness; nLIGHT/Nutronics' approach). The HELSI competition is essentially a live SBC-vs-CBC experiment to determine which architecture wins for production weapons.
Why directed energy matters. A $500 drone can destroy a $5M vehicle; shooting a $1M Stinger at it is unsustainable. Lasers cost dollars per shot (a few kWh) with unlimited "magazines." Every major military is pursuing directed energy; the U.S. leads with HELSI and DE M-SHORAD. Counter-UAS is the most urgent global military need and lasers are the only economically sustainable answer.
Value chain & moat. nLIGHT is vertically integrated from pump diodes through complete weapon systems — a rare position; the only comparable integration in defense lasers is Lockheed Martin (but Lockheed uses slab lasers, not fiber, and doesn't sell components externally). Key technical metrics: wall-plug efficiency, beam quality (M², BPP), brightness (W/sr·m², the key pump-diode metric — nLIGHT claims "unrivaled brightness"), power level (50kW counter-drone / 100–300kW counter-missile / 1MW strategic), beam-combining efficiency, SWaP. Where it sits today: 300kW demonstrated (HELSI Phase 1, exceeded objectives), scaling to 1MW (Phase 2), 50kW delivered for DE M-SHORAD, 450+ patents.
Moat splits cleanly: defense directed energy — strong, durable (300kW demo, $171M HELSI, Nutronics beam-control IP, 450+ patents, security clearances, ITAR locks out Chinese rivals; only real competitor is Lockheed with a different architecture; switching costs very high — qualification cycles, program-specific designs, multi-year relationships). Additive manufacturing (Corona) — moderate (30+ patents, EOS partnership, but IPG/Trumpf could develop competing beam shaping). Commodity industrial lasers — no moat (Chinese competitors sell 30–50% cheaper; nLIGHT has wisely retreated). Medical — weak (thulium displacing holmium:YAG, but multiple entrants).
Customer concentration. The U.S. government is overwhelmingly the largest customer (~50%+; DoD likely exceeds 50% of total revenue). With 67% of revenue from A&D concentrated in a few major programs, the loss of HELSI alone would be devastating — there is not enough commercial revenue to support the current valuation. This concentration is both the bull case (defense spending tailwind) and the bear case (single customer, program risk, political risk). The company doesn't disclose specific customer concentration percentages, which is itself a data point. The internal "partnership" between the Camas laser business and the Longmont beam-control team (from the 2019 Nutronics acquisition) is the foundation of the defense offering.
Financials
Core Four. Growth: revenue FY22 $242.1M (−10.4%) → FY23 $209.9M (−13.3%) → FY24 $198.5M (−5.4%) → LTM FY25 $261.3M (+31.6%); FY26E ~$285M (~+9%). The FY2025 inflection is dramatic — revenue returned to growth, gross margin nearly doubled (16.6% → 29.8%), operating loss narrowed (−$65.6M → −$26.6M), and Q4 FY2025 was GAAP profitable ($4.9M net income) for the first time in recent memory. Margins: GAAP gross 29.8% TTM; EBIT margin −10.2% TTM (improving but still negative). Capital intensity: capex 3–8% of sales. Deployment: no dividend, no buyback executed, $97.4M net cash.
Profitability caveat — 25 years of losses. nLIGHT has "incurred recurring net losses since our inception in 2000" (10-K risk factors). FY2025 showed non-GAAP net income of $13.1M, but GAAP remains in the red and the company earns "non-GAAP profit" only by excluding $33.4M of SBC. ROIC is negative (negative operating income) — currently destroying economic value on a GAAP basis.
Income statement & margins:
| Metric | FY2022 | FY2023 | FY2024 | LTM (FY25) | FY2026E |
|---|---|---|---|---|---|
| Revenue | $242.1M | $209.9M | $198.5M | $261.3M | ~$285M |
| Revenue growth YoY | −10.4% | −13.3% | −5.4% | +31.6% | ~+9% |
| Gross profit | $50.8M | $46.1M | $33.0M | $78.1M | — |
| Gross margin % | 21.0% | 22.0% | 16.6% | 29.8% | — |
| R&D | $53.8M | $46.2M | $45.1M | $48.0M | — |
| SG&A | $48.3M | $45.9M | $49.3M | $54.2M | — |
| EBIT | −$55.1M | −$46.8M | −$65.6M | −$26.6M | — |
| EBIT margin % | −22.8% | −22.3% | −33.0% | −10.2% | — |
| Net income | −$54.6M | −$41.7M | −$60.8M | −$23.5M | — |
| Net margin % | −22.6% | −19.9% | −30.6% | −9.0% | — |
| EPS | −$1.23 | −$0.90 | −$1.27 | −$0.47 | ~$0.30 |
Cash flow & balance sheet:
| Metric | FY2022 | FY2023 | FY2024 | LTM (FY25) |
|---|---|---|---|---|
| Operating cash flow | −$14.5M | $10.1M | −$2.4M | $21.3M |
| Capex | $21.4M | $5.3M | $7.9M | $9.0M |
| Free cash flow | −$35.9M | $4.8M | −$10.3M | $12.3M |
| FCF margin % | −14.8% | 2.3% | −5.2% | 4.7% |
| Cash & equivalents | — | — | — | $133.6M |
| Total debt | — | — | — | $36.2M |
| Net cash | — | — | — | $97.4M |
| Shares outstanding | 44.0M | 46.0M | 48.0M | 55.8M |
| SBC (CF add-back) | $26.8M | $25.8M | $25.0M | $33.4M |
Incremental margins (last 8 quarters) — the genuine bright spot. Quarterly revenue ramped from $44.5M (Q1 FY24) to $81.2M (Q4 FY25), with gross margin climbing from the teens to ~31%. (Q4 FY24 gross profit cratered to 2.4% on a ~$6M non-routine industrial inventory charge — a one-time event that distorts the YoY comparison.) On a 4-quarter-average basis, incremental gross margin ~71.5% and incremental EBIT margin ~62.3% vs reported gross margin of 29.8% — each incremental dollar of new (mostly defense) revenue throws off ~71 cents of gross profit. Q1 FY25 was the standout (88% incremental gross / 71% incremental EBIT, likely the HELSI development ramp). The path to GAAP profitability is visible: if nLIGHT sustains 60–70% incremental EBIT margins as revenue scales toward $350–400M+, EBIT margins of 5–10% are reachable — a fundamental break from the "always unprofitable" narrative. But if growth stalls, the fixed cost base swallows the margin expansion.
Quarterly cadence (GAAP):
| Quarter | Revenue ($K) | Gross Profit ($K) | Gross Margin | EBIT ($K) |
|---|---|---|---|---|
| Q1 FY24 | 44,527 | 7,488 | 16.8% | −14,718 |
| Q2 FY24 | 50,511 | 11,850 | 23.5% | −12,690 |
| Q3 FY24 | 56,129 | 12,550 | 22.4% | −11,799 |
| Q4 FY24 | 47,381 | 1,137 | 2.4% | −26,429 |
| Q1 FY25 | 51,697 | 13,803 | 26.7% | −9,600 |
| Q2 FY25 | 61,735 | 18,457 | 29.9% | −4,236 |
| Q3 FY25 | 66,713 | 20,748 | 31.1% | −7,309 |
| Q4 FY25 | 81,185 | 24,924 | 30.7% | −5,405 |
Industry landscape
A vertically integrated fiber-laser play riding two distinct markets: defense directed energy (early-formation, pre-cycle, the growth engine) and Western industrial/commercial photonics (mid-to-late cycle, structurally challenged). Sector context: see defense-technology, optical-components.
The competitive picture splits in two. Defense directed energy is in early formation, structuring around 2–3 primes (Lockheed Martin, RTX/Raytheon, Northrop Grumman) and 2–3 merchant laser suppliers (nLIGHT, potentially IPG if it enters). The current phase is R&D/prototype — production-scale contracts haven't been awarded; the development-to-production transition (expected 2028–2030) determines who captures the largest revenue pools. This is the "picks and shovels" moment for laser weapons. Industrial fiber lasers are consolidating at the top (IPG, Trumpf, Coherent) while fragmenting at the bottom (dozens of Chinese makers); Western players are losing pricing power and retreating to higher-value niches (AM, EV welding, medical) — IPG's revenue fell from $1.46B (2021) to $977M (2024).
Peer set & relative valuation:
| Metric | LASR | IPGP | COHR | LITE |
|---|---|---|---|---|
| EV/Revenue (TTM) | 13.7x | 3.5x | 3.7x | 5.8x |
| P/E (TTM) | N/M | ~113x | N/M | ~35x |
| EV/EBITDA | ~152x | ~30x | ~22x | ~18x |
| Revenue growth (TTM) | +31.6% | +2.7% | +22.7% | +18.6% |
| Gross margin | 29.8% | 38.0% | 35.2% | 45%+ |
The most telling comparison: nLIGHT and IPG Photonics have nearly identical market caps (~$3.67B vs ~$3.5B), but IPG has 4x the revenue, is profitable, and has far more employees. nLIGHT trades at ~14x sales (3–4x IPG's 3.5x) despite IPG's higher gross margins and actual profitability. The market is paying a massive premium for nLIGHT's defense growth story.
TAM: directed energy weapons ~$2B → $5–10B+ by 2030 (~15–25% CAGR); global fiber laser ~$6B → ~$9–10B (~8–10%); metal additive manufacturing ~$3–4B → ~$8–12B (~20–25%); medical fiber lasers ~$758M → ~$1.2B (~8–10%). Secular tailwinds: counter-UAS urgency (Ukraine, Israel/Iran have proven lasers are a necessity, not a science project), bipartisan defense budget growth, supply-chain reshoring (DoD preference for U.S.-made components), AM adoption moving from prototyping to production.
Management
Overall management grade: B+. Strong technical founder, strong and strengthening team — but below-average governance, an excessive SBC burden, and an all-selling-no-buying insider pattern. The biggest investor question: is the SBC load the price of building a directed energy franchise from scratch, or chronic value transfer from shareholders to insiders? The answer hinges on whether HELSI/defense revenue scales fast enough to shrink SBC as a percentage of a much larger base.
Leadership.
| Name | Title | Tenure | Background |
|---|---|---|---|
| Scott H. Keeney | Co-Founder, Chairman, President & CEO | CEO since July 2000 (25+ yrs); Chairman since Feb 2018 | ~62 (born 1964). BA Econ U. Washington; MBA Harvard. Pacific Coast Feather Co. (mfg/quality) → McKinsey (1993–98) → Aculight CEO (1998–2000, later sold to Lockheed Martin). 2007 E&Y Entrepreneur of the Year (Pacific NW). Founded STEM non-profit nConnect. |
| Joseph Corso | CFO | CFO since March 2022 (at nLIGHT since 2020) | ~44. BA Econ Swarthmore. Thomas Weisel Partners (analyst→VP) → Stifel 15+ yrs (Global Co-Head Electronics & Industrial Tech). Hired as VP Corp Dev & IR in 2020, promoted to CFO; replaced Ran Bareket (retired March 2022). |
| Chris Schechter | COO | Since 2022 | BS/MS Mech Eng MIT, MBA MIT Sloan. Celestica (VP Ops, A&D segment), Zodiac Seats, StandardAero, Parker Hannifin (Clarcor integration), Axcelis Technologies (Lean Six Sigma). Strong A&D operations pedigree. |
| Robert Martinsen | CTO | Long-tenured (internal) | MS EE/Ocean Eng MIT (1989–91). Ex-Coherent, Novalux, Corporation for Laser Optics Research (COLOR). The technical backbone. |
| Jason Farmer | Co-Founder | Since founding (2000) | BS Physics UCSB; MS/PhD Astrophysics U. Colorado. 10+ semiconductor-laser patents; previously CTO; began at Aculight on solid-state/nonlinear optics. Less public-facing now. |
Other key execs: James Nias (VP, Corporate Controller & CAO), Kerry Hill CPA (Chief Administrative Officer, VP HR), John Warren Marchetti (VP Corporate Development & IR), Julie Dimmick JD (VP, General Counsel & Corporate Secretary), Bill Willson (Managing Director, Fiber Division).
Keeney is the real deal as a founder-CEO — McKinsey strategy, deep laser-industry knowledge from Aculight, and a genuinely impressive defense pivot (A&D 36%→67% of revenue) that turned a commercial laser maker into a weapons supplier. The concern: 25 years without sustained GAAP profitability — the story has always been "profitability is around the corner." No C-suite departures in the last 2 years; the team is stable and strengthened with A&D-experienced additions (COO Schechter; the CFO executed the $201M Feb 2026 raise).
Insider ownership & skin in the game — the elephant: ALL selling, ZERO buying.
| Name | Role | Shares | % O/S | Est. Value |
|---|---|---|---|---|
| Scott Keeney | CEO | 2,229,125 direct + 4,474 indirect (Keeney Family Revocable Trust; incl. unvested RSUs) | ~4.0% | ~$147M |
| Joseph Corso | CFO | ~265,418 (incl. unvested RSUs) | ~0.5% | ~$17.5M |
| Jason Farmer | Co-Founder | Undisclosed | — | — |
Over $20M in insider sales across 23 transactions in the last six months, with zero insider purchases. 90-day net: −$3.0M, three executives, all sales. Key sales: Keeney 15,391 @ $28.84 (Sep 2025, 10b5-1); Link (Dir) 12,560 @ $35.33 (Nov 2025); Keeney ~24,996 @ ~$34–36 (Dec 2025); Keeney 55,895 @ $58–63 (~$3.4M, Mar 2026, 10b5-1 + tax); Keeney 19,096 @ $56–61 (Mar 2026); Corso 13,038 @ ~$60 (Mar 2026); Link 25,404 @ $62–64 (~$1.6M, Mar 2026). Mitigants: most under pre-set 10b5-1 plans (adopted 12 Jun 2025 and 11 Dec 2025); some CEO sales were mandatory sell-to-cover for RSU tax; stock ran $6→$70, so taking profit off a 10x move is rational; Keeney still holds 2.2M+ shares (sold ~115K, ~5% of position). Concern level MODERATE — the total absence of any insider buying, even a token open-market purchase during a vertical move, is notable. Top holders: Vanguard ~4.99M (~9.6%), BlackRock ~4.64M (~8.9%), Harvey Partners 2.11M (~4.0%, value small-cap), Needham Investment Mgmt ~1.86M (~3.6%, also covers the stock). ~81–84% institutional, 286 holders. Recent: Divisar Capital dumped ~$9.6M (Mar 2026); Portolan took a new 770K position (Q3 2025); Vanguard +125K; Needham +65K.
Capital allocation — grade B+. The Nutronics acquisition (2019) was a home run — ~$33M total ($17.5M cash + $15.8M RSUs) for the 32-person Longmont, CO beam-control & adaptive-optics shop (founded 1995) that became the foundation of nLIGHT's directed energy capability, leading directly to HELSI ($171M+) and DE M-SHORAD ($34.5M); the current $3.67B market cap is substantially attributable to this deal. Smaller strategic M&A: Liekki Oy (~2008–09, Finland specialty fiber, clean vertical-integration); OPI Photonics (~2020, Torino, Italy, low-profile tuck-in); plasmo Industrietechnik (Feb 2022, laser process monitoring). The buyback that never happened: a $10M program authorized Nov 2019 to offset Nutronics RSU dilution had repurchased zero shares as of 31 Dec 2024 — management authorized a buyback they never used while diluting via SBC. Equity issuance: the Feb 2026 offering raised $201M (4.57M shares at $44, ~9.2% dilution) for Longmont expansion + working capital; awkward timing — shares sold to the public at $44, then insiders sold at $60+ once 60-day lockups expired in early April. Capex conservative (FY21 $19.3M / FY22 $21.4M / FY23 $5.3M / FY24 $7.9M / FY25 $9.0M). R&D consistently 18–23% of revenue (FY21 $54.8M/20.3% … FY25 $48.0M/18.4%) with strong outcomes (300kW demo, 450+ patents, Corona, CBC).
Compensation & alignment. FY2024 CEO total $5,139,076 (base $454,077; cash incentive $0 — both targets missed: Revenue $198.5M vs $232.1M target, Adj. EBITDA −$17.2M vs $7.2M target; stock awards $4,672,500; other $12,499). The plan has teeth — 90% of target TDC is equity + variable cash, 10% base; annual cash incentive 25% revenue / 75% adj. EBITDA; FY24 bonus literally zero. Equity is 50% time-based / 50% performance RSUs (Monte Carlo TSR vesting). Say-on-pay ~97%. Double-trigger CIC, no tax gross-ups, clawback policy, hedging/pledging prohibited. The 2025 special performance awards (Aug 2025): up to 2.2M shares (1.2M CEO, 1.0M other senior leadership, ~4% of O/S) as price-hurdle PRSUs requiring sustained 60-day VWAP of $30/$35/$40; LASR was $15–20 at grant, so these were real stretch targets — the stock has since blown through all thresholds, so substantial vesting is likely (significant dilution, but the performance-based design is right).
SBC is the single biggest compensation red flag — a tax on shareholders:
| Year | Revenue | SBC | SBC % of Revenue |
|---|---|---|---|
| FY2021 | $270M | $37.7M | 14.0% |
| FY2022 | $242M | $26.8M | 11.1% |
| FY2023 | $210M | $25.8M | 12.3% |
| FY2024 | $199M | $25.0M | 12.6% |
| FY2025 | $261M | $33.4M | 12.8% |
SBC running 11–14% of revenue every year is the primary reason nLIGHT has never been sustainably GAAP profitable despite $261M revenue. SBC by function (10-K, FY24): CoR $2,438K, R&D $7,505K, SG&A $15,018K (largest and fastest-growing) = $24,961K total. (Cash-flow-statement SBC of $33.4M for FY25 may include additional items.) Share count: IPO (2018) 33.0M → FY22 44.0M → FY23 46.0M → FY24 48.0M → FY25 50.0M → current 55.79M — a 69% increase in 8 years; the Feb 2026 offering alone added 4.57M (~10% in a single event); SBC alone dilutes ~4–5% annually.
Board & governance — grade Red (ISS QualityScore 8/10, where 10 = worst). Classified (staggered) board, 3 classes, 3-yr terms. 6 of 7 directors independent (Keeney sole non-independent).
| Director | Class | Independent | Since | Background | Committees |
|---|---|---|---|---|---|
| Scott Keeney | — | No (CEO) | 2000 | Founder/CEO | Chairman |
| Bill Gossman | — | Yes | 2016 | Venture Partner, Mohr Davidow (2009–18) | Lead Independent Director, Comp Chair |
| Raymond Link | — | Yes | 2010 (16 yrs) | Ex-CFO FEI, TriQuint, Sawtek; CPA, Wharton MBA | Audit Chair, Comp |
| Bandel Carano | — | Yes | 2001 (25 yrs) | Managing Partner, Oak Investment Partners; BS/MS EE Stanford. Also on NextNav board | Comp (since Mar 2025), IT Security |
| Geoffrey Moore | — | Yes | 2013 | Author "Crossing the Chasm"; PhD English Lit, UW. Also WorkFusion, Phaidra boards | — |
| Mark Hartman | III | Yes | Jun 2025 | Ex-CFO Woodward (16 yrs); CPA, Kellogg MBA | Audit |
| Gerald Haines | I | Yes | Jan 2026 | Ex-CFO Mercury Systems, Metabolon; EVP/CFO Impulse Dynamics; JD Cornell Law | Audit |
Board is refreshing in the right direction — two strong A&D financial experts (Hartman, Haines) added 2025–26, replacing VC-era directors (Doug Carlisle resigned June 2025 after 24 years since 2001, replaced by Hartman). But Bandel Carano has 25 years' tenure ("independent" becomes theoretical) and Geoffrey Moore is a marketing guru with a PhD in English literature, not a laser/defense expert. ISS pillars: Overall 8, Audit 6, Board 9, Shareholder Rights 8, Compensation 7.
Anti-takeover provisions are fortress-level: classified board, blank-check preferred (5M shares — functionally a poison-pill authorization), no cumulative voting, board fills vacancies, director removal only for cause, no written consent, supermajority (two-thirds) amendment requirement, special meetings only by chairman/CEO/board, advance-notice requirements, exclusive forum (Delaware Chancery), Delaware Section 203, and Washington-state anti-takeover protections. For a company controlled by a founder-CEO with only 4% ownership, these effectively entrench management.
Forensic checks — clean. No related-party transactions, no shell entities, no revenue circularity, no SEC enforcement, no restatements, no material-weakness findings; clean KPMG (Portland, OR) audit, effective ICFR. No activist campaigns, no shareholder proposals. One minor blemish: a 2015 False Claims Act settlement ($420K) over SBIR-grant eligibility (period 2004–2013) — multiple VC firms owned >51% of nLight, technically disqualifying it from the small-business program; the government stated there was "no indication that nLight did not adequately perform the work," and the company itself flagged the issue to a DOE contracting officer (transparency, not concealment). Immaterial on $15M+ of grants. No personal red flags on Keeney (no SEC actions, lawsuits, or bankruptcies).
Catalysts & risks
Near-term catalysts (0–12 months): Q1 FY2026 earnings (7 May 2026; guidance $60–65M revenue — watch continued defense acceleration and margin expansion); HELSI Phase 2 milestones / demonstration or test results; new counter-UAS or directed energy contract awards from Army/Navy/Air Force; production-contract announcements (the single most important catalyst — the development-to-production transition). Monthly defense-contract news and analyst revisions move a thinly covered ($3.7B, 8 analysts) name sharply.
Medium-term catalysts (1–3 years): DE M-SHORAD integration completion (50kW fielded on Stryker, IOC ~2026–27); HELSI megawatt-class demonstration (~2027–28, transformational); EOS product launches incorporating Corona AFX (validating commercial AM revenue); sustained GAAP profitability (narrative-changing after 25 years of losses). The big money is the production-contract selection — the Army choosing nLIGHT's fiber-based approach vs. Lockheed's slab-based approach for fielded systems, likely 2028–2030, worth potentially billions. Until then, the stock trades on expectation.
Risks (structured):
- Valuation correction (High) — ~14x sales with negative GAAP earnings; any growth disappointment triggers a sharp correction. The single most likely source of loss, independent of the business.
- Customer concentration (High) — DoD likely 50%+ of revenue; loss of HELSI would be devastating; mitigated only slowly as commercial (EOS, medical TFL) diversifies.
- Continued dilution (High) — SBC alone dilutes ~4–5%/yr; share count +69% since IPO; closes only on sustainable positive FCF that stops equity issuance.
- Lockheed Martin wins production selection (Medium) — different architecture (fiber vs slab); resolves at production selection (~2028–2030); Army may fund both.
- HELSI megawatt scaling fails (Low–Medium) — exceeded Phase 1 at 300kW; Phase 2 milestones progressively de-risk; closes when 1MW demonstrated (~2027–28).
- Defense program delay/cancellation, budget sequestration or continuing-resolution freeze (Medium) — structural to the defense industry; reduced (not closed) by multiple concurrent Army/Navy/Air Force programs.
- Chinese commoditization of industrial lasers (already happening, Medium impact) — mitigated by the pivot to defense (ITAR-protected) and differentiated AM (Corona patents).
- Governance / entrenchment (structural) — fortress anti-takeover provisions, ISS 8/10, classified board, founder-CEO at 4% ownership.
Dilution detail: share count 33M→55.8M since 2018 (+69%); annual SBC dilution ~4–5%; Feb 2026 offering ~9.2% (4.57M @ $44); 2025 special awards up to 2.2M (~4%); no identified ATM/shelf. Turned FCF-positive in FY2025 ($12.3M) but not yet sufficient to self-fund growth.
Bear case. HELSI Phase 2 hits a technical wall at megawatt scale (beam quality degrades, thermal management fails); the Army selects Lockheed's architecture for production; defense budget freezes under a continuing resolution; revenue growth slows to single digits as development contracts wind down and production contracts are delayed; the stock de-rates from 14x to 5x EV/Revenue — a ~65% decline to ~$23/share. Downside target $20–25 (roughly where the stock traded six months before the deep-dive). Thesis invalidation: HELSI Phase 2 technical failure, or the U.S. military concluding fiber-based lasers can't scale to megawatt-class — would remove the core growth narrative and likely return the stock to $10–15 (pre-defense-pivot levels).
Valuation / DCF
No full DCF modeled. Expensive on any near-term number; defensible only if directed energy production contracts materialize.
- Relative valuation: ~13.7x EV/Revenue is 3–4x what IPG trades at, despite IPG's 4x revenue, higher gross margin, and profitability. The stock's current multiple is the highest in its public history (it has ranged from ~1x EV/Revenue in the 2022–24 trough to ~14x today).
- What the market is pricing in: at $3.57B EV on $261M LTM revenue, the market implies nLIGHT grows revenue to ~$700–800M+ and achieves 15–20% operating margins within 4–5 years (terminal EV/Revenue 5–6x) — nearly tripling revenue while dramatically expanding margins. Possible if directed energy production contracts land, but a lot to pay today. To merely maintain a 9x EV/Revenue multiple, revenue needs to reach ~$400M+ within two years; GAAP profitability must be demonstrated and sustained; production contracts (not just development) must be awarded; and HELSI megawatt scaling must succeed.
- The analyst disconnect: consensus average target $50.56 is ~23% below the current price — even the bulls think the stock is ahead of itself. The street-high $95 (Baird, 4 Mar 2026) is a significant outlier and still requires a lot to go right.
Entry zones / position plan. Conviction Medium. Suggested sizing: small (1–2% of portfolio) if initiating; beta 2.34 means a 10% market correction could mean a 20%+ LASR drawdown. Scale in, don't lump — initial tranche at ~$65 only if you want defense-thesis exposure; add on pullbacks to $45–50 (closer to analyst consensus); full position only after confirmation of HELSI Phase 2 progress or a production-contract award.
Decision log
2026-03-21/22 — Consolidated initial coverage (deep-dive 22 Mar + mgmt-DD 21 Mar):
- Deep-dive — WATCH / "right company, possibly wrong price," Medium conviction at $65.76. Excellent technology positioning (one of 2–3 companies with demonstrated 300kW+ directed energy capability; $171M HELSI; 450+ patents; genuine 71% incremental gross / 62% incremental EBIT margins) against a dangerous valuation (~14x sales, no sustained GAAP profit, consensus target $50.56 = −23%). Expected return to consensus −23%. Bear target $20–25 (−65% on a de-rate to 5x EV/Revenue). Next gates: Q1 FY26 (7 May), HELSI Phase 2 milestones, production-contract selection vs Lockheed (~2028–30).
- Management DD — Grade B+. Keeney is a genuine technical founder-CEO; Nutronics ($33M → the directed energy franchise) was a home run; comp plan has teeth (FY24 bonus $0); clean forensics (trivial 2015 SBIR settlement only). But: SBC at 11–14% of revenue is the primary cause of 25 years of GAAP losses (share count +69% since IPO); all-selling-zero-buying insider pattern ($20M+/6mo); fortress anti-takeover governance (ISS 8/10, Board pillar 9); $201M Feb-2026 raise at $44 followed by insider sales at $60+. The investor question: is the SBC the price of building the franchise, or chronic value transfer? Answer depends on whether HELSI scales fast enough to shrink SBC against a much larger base — works at $500M+ revenue, fails if growth stalls.
Position plan. WATCH at spot — watchlist slot, not full size. Scale in on pullbacks to $45–50; full size only on HELSI Phase 2 progress or a production-contract award. Re-evaluate / max-loss triggers — positive: HELSI Phase 2 milestones exceeded, production contract award, sustained GAAP profitability, insider buying. Negative: HELSI technical setback, defense budget cuts, loss of a contract to Lockheed, revenue growth deceleration below 15%, significant insider-selling acceleration. Exit: HELSI Phase 2 failure or the Army selecting a non-nLIGHT architecture for production — removes the core thesis.
Net stance: a good company you want to own, at a price you should not chase. Scale in; don't lump.
Sources
Fragments folded into this canonical page (consolidated 2026-06-02; originals archived to _migration-archive/2026-06-02/LASR/): lasr.md deep-dive spine (22 Mar 2026; auto-maintained through 31 May 2026 incl. Citrini EW-basket source update) · lasr-mgmt-dd.md (21 Mar 2026 — deep forensic management & governance, folded into Management).
Filings history (sanctioned second file): lasr-filings — chronological earnings/filing log (run /filings LASR to populate).
Related vault pages: defense-technology · optical-components
Briefings:
- 2026-03-21 · nLIGHT (LASR) · vault
Source updates (auto-maintained):
- Citrini — Electronic Warfare Basket (2025-06-20): nLIGHT (LASR) appears at a 1.95% weight, the lightest among laser/photonics peers (IPG Photonics 2.03%; heavier weights to drone, C2, and EW specialists). The thin basket weight signals that institutional EW-thematic allocators see LASR as a peripheral laser supplier rather than a core EW platform — consistent with the "right company, possibly wrong price" caution. Source:
dropfile://Citrini Articles/Baskets/Citrini - Electronic Warfare Basket 2025-06-20.csv
Key external sources: nLIGHT 10-K FY2024 · Q4 FY2025 earnings release (26 Feb 2026) · DEF 14A proxy · HELSI Phase 2 $171M · DE M-SHORAD $34.5M · $201M equity offering · Nutronics acquisition (2019) · Gerald Haines board appointment · Mark Hartman board appointment · CEO special 1.2M-share award · Form 4 insider sales · CFO transition (Bareket→Corso) · 2015 False Claims Act settlement · Baird initiation $95 — 247WallSt · LASR financials — StockAnalysis · IPGP financials — StockAnalysis · nLIGHT product pages (nlight.net); Scott Keeney — Wikipedia. EOS partnership announcement (Jun 2024).